Navigation Links
The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
Date:4/3/2008

Announces business plans for patient recruitment for the balance of the

year

WELLINGTON, Fla., April 3, 2008 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) announced today that, following an open enrollment period instituted by The Centers for Medicare and Medicaid Services (CMS), the Company's subsidiary, Renaissance Health Systems, increased its enrolled Medicare Advantage base to 2,240 and is on track to reach a projected 5,000 enrollments by December 31, 2008.

During the CMS open enrollment period, which runs from November 15th through March 31st of each year, Medicare-eligible patients are allowed to choose or switch health plans. Patients who come of eligible age for Medicare or Medicaid during the balance of the year as well as those who become eligible to receive both Medicaid and Medicare benefits or are eligible for special needs waivers, are able to select a plan year round.

Noel J. Guillama, President and CEO of The Quantum Group, stated earlier this week that the Company plans to continue recruitment of Medicare eligible individuals for the remainder of the year. Mr. Guillama said, "The state of Florida welcomes new residents by the thousands each month, many of which are Medicare-eligible and looking to retire in the Sunshine State. We will continue to work with our HMO partners to pursue marketing initiatives geared to the newly Medicare eligible, those who are receiving both Medicare and Medicaid benefits as well as those with special needs waivers."

Guillama continued, "We are also in discussions with our HMO partners to cultivate new or transferred providers and/or patient assignments who are already enrolled in Medicare Advantage plans with each respective HMO.

"Our strategy is on track to focus on the continued growth of our provider base and enhancement of o
'/>"/>

SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The Quantum Group Extends CEOs Employment Agreement
2. The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2008
3. The Quantum Group Announces Strategic Technology Alliance
4. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
5. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
6. The Quantum Group, Inc. Announces Separation of Units
7. Results promising for computational quantum chemical methods for drug development
8. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
9. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
10. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
11. Quantum light beams good for fast technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...Y., Sept. 5 /PRNewswire/ -- Tonight is a momentous...entertainment industry,executives, celebrities and...advocacy join forces to Stand Up to Cancer. This c...8:00 p.m. to 9:00 p.m. ET on the three,networks --...orm to elevate,the discussion about cancer and the...
(Date:9/5/2008)... /PRNewswire/ -- EthicAd, a nonprofit organization...er education, announces,the launch of a new FDA We...nderstand direct-to-consumer (DTC) advertising of ...t Prescription Drug Advertising," is,hosted by the... was,developed by the FDA in partnership with Ethi...
(Date:9/5/2008)... sorafenib helps reverse disease resistance to ant...HealthDay News) -- The drug sorafenib may help "re...ormonal drugs, Georgetown University Medical Cent...tor or progesterone-receptor positive (ER or PR po...hormonal medicines, such as aromatase inhibitors, ...
(Date:9/5/2008)...cer risk prediction models are enhanced by taking ... DNA repair capacity, according to research teams ...M. D. Anderson Cancer Center in two complementary ... Prevention Research . , In the first study to f...e results based on increased exposure to certain r...
Breaking Medicine News(10 mins):Health News:The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years 2Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3
...squito repellants resembling human body odour whic...t resemble the odour of people who don't get bitte... to prevent the spread of insect-borne diseases su...n developing countries. Some people produce repell...
...hed yesterday for the betterment of the lives of t...s in the midst of a growing concern about the need...tment in Scotland. Charities, the National Rheuma...are have called on the health authorities to ensur...
...ts on banning sugary drinks from schools have met ... Health Minister Pete Hodgson’s idea to make all s... the obesity epidemic has been described as "misgu...ociate Professor Wayne Cutfield and Dr Paul Hofman...
...ty of Oxford have claimed that their study that in... still be very widespread among young children//. ... cough, which is also known as ‘Pertussis’. This b... killer with reports of almost 100,000 cases a yea...
Other Medicine News:Health News:Campaign For Arthritis Awareness Launched In Scotland 2Health News:Anti-Obesity Groups Criticize Response of Medical Professionals 2Health News:Researchers Warn That Whooping Cough Is Still Very Prevalent 2Health News:Researchers Warn That Whooping Cough Is Still Very Prevalent 3
(Date:9/4/2008)...INGHAM, Ala., Sept. 4 /- Southern Res...Institutes of Health (NIH) has selected,the organi...r Libraries,Probe Production Center Network (MLPCN...- is part of the Molecular Libraries Program which...ntific knowledge of the human,genome and validate ...
(Date:9/4/2008)... cohort demonstrates potent antiviral activity and...ofile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-Fi... IDIX ), a biopharmaceutical company engaged,in th...ment of human viral,and other infectious diseases,...f-concept study evaluating IDX899, a non-nucleosid...
(Date:9/3/2008)...ays: Wrong Question Asked. Wrong Children Studied....PRNewswire-USNewswire/ -- A Centers for Disease,Co...aims there is no link,between the MMR vaccine and ... this study does nothing to dispel the growing pub...aises several questions concerning design,and meth...
(Date:9/3/2008)... September is National Vascular Disease Awarenes...e/ -- Diffusion Pharmaceuticals,LLC, a clinical-st...rugs,for the treatment of unmet medical needs, ann...in a Phase I/II clinical trial of its lead drug,ca... designated NCT00725881,on the clinicaltrials.gov ...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4China Clean Energy Updates Business Outlook 6279 1China Clean Energy Updates Business Outlook 6279 2China Clean Energy Updates Business Outlook 6279 3New York Resident Elected President of Lions Clubs International 22871 1New York Resident Elected President of Lions Clubs International 22871 2Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 1Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 2Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 1Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 2
...nts with,predominantly classic subfoveal choroid... the Opal Photoactivator from,Lumenis. Developed...or injection) therapy, the Opal Photoactivator,o...tures,that ensure the highest level of patient c...
Features soft, low friction sheath that extends beyond the tip.
Designed to retain the desired curve during oral intubation.
SunGlide™ Stylette - Grey Child. Use in 4.0 to 7mm tubes. 25/box.
Medicine Products: